TCRX: TScan Therapeutics, Inc. Stock

by  •  • Comments Off on TCRX: TScan Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 89.98
Enterprise Value ($M) -56.64
Book Value ($M) 240.97
Book Value / Share 4.61
Price / Book 0.37
NCAV ($M) 162.57
NCAV / Share 3.11
Price / NCAV 0.55

Profitability (mra)
Return on Invested Capital (ROIC) -0.38
Return on Assets (ROA) -0.53
Return on Equity (ROE) -1.04

Liquidity (mrq)
Quick Ratio 8.14
Current Ratio 8.14

Balance Sheet (mrq) ($M)
Current Assets 292.72
Assets 371.12
Liabilities 130.15
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.82
Operating Income -134.82
Net Income -127.50

Cash Flow Statement (mra) ($M)
Cash From Operations -110.82
Cash from Investing -52.61
Cash from Financing 208.76

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
4 days ago 13G/A BlackRock, Inc. 5.40 -39.01
02-14 13G/A Lynx1 Capital Management LP 10.90 -94.59
02-14 13G/A K2 HealthVentures Equity Trust LLC 6.90 -32.33
02-12 13G/A Adage Capital Partners Gp, L.l.c. 7.13 -10.26
11-14 13G/A Cormorant Asset Management, LP 0.00 -100.00
11-14 13G/A Biotechnology Value Fund L P 9.99 14.91
2024-04-23 13D/A Baker Bros. Advisors Lp 6.10 1.25

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-05 10-K Form 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-25 81,169 241,208 33.65
2025-04-24 125,289 357,933 35.00
2025-04-23 95,932 396,449 24.20
2025-04-22 251,410 939,555 26.76

(click for more detail)

Similar Companies
SUPN – Supernus Pharmaceuticals, Inc. TARA – Protara Therapeutics, Inc.
TBPH – Theravance Biopharma, Inc. TKNO – Alpha Teknova, Inc.
TLPH – Talphera, Inc.


Financial data and stock pages provided by
Fintel.io